<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01626989</url>
  </required_header>
  <id_info>
    <org_study_id>ST-1007-ASV4-MS</org_study_id>
    <nct_id>NCT01626989</nct_id>
  </id_info>
  <brief_title>Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders</brief_title>
  <official_title>Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Respironics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining
      if the new device will treat those participants no worse than when compared to its
      predecessor device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of the BiPAP autoSV4 device in participants with Complex Sleep Apnea Syndrome will
      treat those participants no worse than when compared to its predecessor device, the BiPAP
      autoSV Advanced™, with respect to:

      • Apnea-Hypopnea Index (AHI)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index (AHI)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Apnea-Hypopnea Index (AHI) is the number of apneas and hypopneas per hour of sleep.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) Percentage Based on Total Sleep Time (TST) Indices</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>REM is the period of rapid eye movement sleep, NREM are stages 1, 2, and 3 of sleep, and Total Sleep Time (TST) is the duration of time from &quot;lights out,&quot; or bedtime, to the onset of sleep. The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Apnea Index(CAI)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Central Apnea Index(CAI) is the number of central apneas divided by the number of hours of sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstructive Apnea Index (OAI)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Obstructive Ap8 participants had missing or unscorable data, therefore they are not included in the analysis. nea Index (OAI) is the number of obstructive apneas divided by the number of hours of sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mixed Apnea Index (MAI)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Mixed Apnea Index (MAI) is the number of combination of central and obstructive apneas divided by the number of hours of sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Onset Latency (SOL)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Sleep Onset Latency (SOL) is the amount of time it takes to fall asleep after the lights have been turned off.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>REM Onset Latency (ROL)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>REM Onset Latency (ROL) is defined as the time it takes to get into REM sleep from Sleep Onset.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake After Sleep Onset (WASO)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Wake After Sleep Onset (WASO) is a statistic used in sleep studies to determine the amount of time a person spends awake, starting from when they first fall asleep to when they become fully awake and do not attempt to go back to sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Sleep Time (TST)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Total Sleep Time (TST). Total Sleep Time (TST) is the duration of time from &quot;lights out,&quot; or bedtime, to waking from sleep. The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency (SE %)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Sleep Efficiency (SE %) is the percentage of time spent asleep while in bed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) sleep. REM is the period of rapid eye movement sleep, NREM are stages 1, 2, and 3 of sleep, and Wake (W) is the duration of time from &quot;lights out,&quot; or bedtime, to the onset of sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal Index</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Arousal Index is the number of arousals and awakenings is registered in the study, and reported as a total number and as a frequency per hour of sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nocturnal Oxygenation</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Nocturnal oxygenation measured by continuous pulse oximetry during sleep study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypopnea Index (HI)</measure>
    <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
    <description>Hypopnea Index (HI) is the number of hypopneas divided by number of hours of sleep.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <condition>Sleep Apnea, Central</condition>
  <arm_group>
    <arm_group_label>BiPAP auto SV Advanced</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BiPAP auto SV Advanced</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BiPAP auto SV 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Auto Servo Ventilation Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP auto Advanced</intervention_name>
    <description>Auto Servo Ventilation Device</description>
    <arm_group_label>BiPAP auto SV Advanced</arm_group_label>
    <other_name>BiPAP Auto SV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP auto SV4</intervention_name>
    <description>Auto Servo Ventilation Device</description>
    <arm_group_label>BiPAP auto SV 4</arm_group_label>
    <other_name>BiPAP Auto SV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21-80

          -  Ability to provide consent

          -  Documentation of medical stability by investigator

          -  Subjects who currently have been on Positive Airway Pressure (PAP) therapy for ≥ 4
             weeks and who previously had a Continuous Positive Airway Pressure (CPAP) titration
             with CAI ≥ 5.

        OR Subjects who currently have been on PAP therapy for ≥ 4 weeks and who had a diagnostic
        study done, with a CAI ≥ 5, and were prescribed PAP therapy without a CPAP titration.

          -  Agreement to undergo a full-night, in-lab research CPAP Titration

          -  Agreement to undergo two full-night, in-lab therapy research Polysomnography (PSG) on
             BiPAP autoSV devices

        Exclusion Criteria:

          -  Major medical or psychiatric condition that would interfere with the demands of the
             study, adherence to positive airway pressure, or the ability to complete the study.
             For example, unstable congestive heart failure, chronic lung disease, neuromuscular
             disease, daytime hypercapnia, cancer, or renal failure.

          -  Systolic blood pressure &lt; 80 mm Hg at Baseline Visit.

          -  Participants in whom PAP therapy is otherwise medically contraindicated.

          -  Participants who are unwilling to wear CPAP

          -  Currently prescribed oxygen therapy (as needed, nocturnal, or continuous

          -  Participants with previously diagnosed respiratory failure or respiratory
             insufficiency and who are known to have chronically elevated arterial carbon dioxide
             levels while awake (PaCO2 ≥ 45mmHg).

          -  Participants who have had surgery of the upper airway, nose, sinus, or middle ear
             within the previous 90 days.

          -  Participants with untreated, non-obstructive Sleep Apnea (OSA)/ Complex Sleep Apnea
             (CSA) sleep disorders, including but not limited to; insomnia, periodic limb movement
             syndrome, or restless legs syndrome (PLM Arousal Index &gt; 15).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shahrokh Javaheri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleepcare Diagnostics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Wylie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arkansas Center for Sleep Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Goetting, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkansas Center for Sleep Medicine</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Health</name>
      <address>
        <city>Portage</city>
        <state>Michigan</state>
        <zip>49024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleepcare Diagnostics</name>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 19, 2011</study_first_submitted>
  <study_first_submitted_qc>June 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2012</study_first_posted>
  <results_first_submitted>February 8, 2019</results_first_submitted>
  <results_first_submitted_qc>April 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 25, 2019</results_first_posted>
  <last_update_submitted>April 23, 2019</last_update_submitted>
  <last_update_submitted_qc>April 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Screening Population</title>
          <description>All patients that signed consent are considered for the screening population.</description>
        </group>
        <group group_id="P2">
          <title>BiPAP Auto SV Advanced First, Then BiPAP Auto SV 4</title>
          <description>Participants received the Philips BiPAP Auto SV Advanced for one night, then received the BiPAP Auto SV 4 for one night.</description>
        </group>
        <group group_id="P3">
          <title>BiPAP Auto SV 4 First, Then BiPAP Auto SV Advanced</title>
          <description>Participants received the Philips BiPAP Auto SV 4 for one night, then received the BiPAP Auto SV Advanced for one night</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Screening Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Screen Failure</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Fist Intervention (Night 1)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (Night 2)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All participants that signed consent.</population>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>All study participants that signed consent.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.71" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.3" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Apnea-Hypopnea Index (AHI)</title>
        <description>Apnea-Hypopnea Index (AHI) is the number of apneas and hypopneas per hour of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline Polysomnograph (PSG) to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea-Hypopnea Index (AHI)</title>
          <description>Apnea-Hypopnea Index (AHI) is the number of apneas and hypopneas per hour of sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38" spread="31"/>
                    <measurement group_id="O2" value="13" spread="17"/>
                    <measurement group_id="O3" value="12" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Friedman Test comparing all 3 nights</non_inferiority_desc>
            <p_value>.001</p_value>
            <method>nonparametric Wilcoxon Signed Rank test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) Percentage Based on Total Sleep Time (TST) Indices</title>
        <description>REM is the period of rapid eye movement sleep, NREM are stages 1, 2, and 3 of sleep, and Total Sleep Time (TST) is the duration of time from &quot;lights out,&quot; or bedtime, to the onset of sleep. The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Non Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) Percentage Based on Total Sleep Time (TST) Indices</title>
          <description>REM is the period of rapid eye movement sleep, NREM are stages 1, 2, and 3 of sleep, and Total Sleep Time (TST) is the duration of time from &quot;lights out,&quot; or bedtime, to the onset of sleep. The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>percent of TST</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Stage 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" spread="14"/>
                    <measurement group_id="O2" value="18" spread="10"/>
                    <measurement group_id="O3" value="17" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" spread="14"/>
                    <measurement group_id="O2" value="65" spread="13"/>
                    <measurement group_id="O3" value="65" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="8"/>
                    <measurement group_id="O2" value="4" spread="6"/>
                    <measurement group_id="O3" value="5" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>REM</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" spread="9"/>
                    <measurement group_id="O2" value="13" spread="9"/>
                    <measurement group_id="O3" value="14" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central Apnea Index(CAI)</title>
        <description>Central Apnea Index(CAI) is the number of central apneas divided by the number of hours of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis. 8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Central Apnea Index(CAI)</title>
          <description>Central Apnea Index(CAI) is the number of central apneas divided by the number of hours of sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis. 8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" spread="15"/>
                    <measurement group_id="O2" value="1" spread="2"/>
                    <measurement group_id="O3" value="1" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Obstructive Apnea Index (OAI)</title>
        <description>Obstructive Ap8 participants had missing or unscorable data, therefore they are not included in the analysis. nea Index (OAI) is the number of obstructive apneas divided by the number of hours of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Obstructive Apnea Index (OAI)</title>
          <description>Obstructive Ap8 participants had missing or unscorable data, therefore they are not included in the analysis. nea Index (OAI) is the number of obstructive apneas divided by the number of hours of sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" spread="10"/>
                    <measurement group_id="O2" value="1" spread="2"/>
                    <measurement group_id="O3" value="2" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mixed Apnea Index (MAI)</title>
        <description>Mixed Apnea Index (MAI) is the number of combination of central and obstructive apneas divided by the number of hours of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Mixed Apnea Index (MAI)</title>
          <description>Mixed Apnea Index (MAI) is the number of combination of central and obstructive apneas divided by the number of hours of sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" spread="7"/>
                    <measurement group_id="O2" value="0.3" spread="0.6"/>
                    <measurement group_id="O3" value="0.6" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Onset Latency (SOL)</title>
        <description>Sleep Onset Latency (SOL) is the amount of time it takes to fall asleep after the lights have been turned off.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Onset Latency (SOL)</title>
          <description>Sleep Onset Latency (SOL) is the amount of time it takes to fall asleep after the lights have been turned off.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.6" spread="16.3"/>
                    <measurement group_id="O2" value="19.3" spread="10.1"/>
                    <measurement group_id="O3" value="24.3" spread="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>REM Onset Latency (ROL)</title>
        <description>REM Onset Latency (ROL) is defined as the time it takes to get into REM sleep from Sleep Onset.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>REM onset latency is not a standard set of sleep scores analyzed. This is not apart of the analysis, this is in the protocol by error. However the protocol was not amended.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>REM Onset Latency (ROL)</title>
          <description>REM Onset Latency (ROL) is defined as the time it takes to get into REM sleep from Sleep Onset.</description>
          <population>REM onset latency is not a standard set of sleep scores analyzed. This is not apart of the analysis, this is in the protocol by error. However the protocol was not amended.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wake After Sleep Onset (WASO)</title>
        <description>Wake After Sleep Onset (WASO) is a statistic used in sleep studies to determine the amount of time a person spends awake, starting from when they first fall asleep to when they become fully awake and do not attempt to go back to sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Wake After Sleep Onset (WASO)</title>
          <description>Wake After Sleep Onset (WASO) is a statistic used in sleep studies to determine the amount of time a person spends awake, starting from when they first fall asleep to when they become fully awake and do not attempt to go back to sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.1" spread="48"/>
                    <measurement group_id="O2" value="64.1" spread="57.6"/>
                    <measurement group_id="O3" value="54.2" spread="29.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Sleep Time (TST)</title>
        <description>Total Sleep Time (TST). Total Sleep Time (TST) is the duration of time from &quot;lights out,&quot; or bedtime, to waking from sleep. The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Total Sleep Time (TST)</title>
          <description>Total Sleep Time (TST). Total Sleep Time (TST) is the duration of time from &quot;lights out,&quot; or bedtime, to waking from sleep. The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="354.0" spread="74.3"/>
                    <measurement group_id="O2" value="352.4" spread="69.2"/>
                    <measurement group_id="O3" value="368.1" spread="64.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Efficiency (SE %)</title>
        <description>Sleep Efficiency (SE %) is the percentage of time spent asleep while in bed.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Efficiency (SE %)</title>
          <description>Sleep Efficiency (SE %) is the percentage of time spent asleep while in bed.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>percent of time asleep</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" spread="13"/>
                    <measurement group_id="O2" value="81" spread="12"/>
                    <measurement group_id="O3" value="82" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep</title>
        <description>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) sleep. REM is the period of rapid eye movement sleep, NREM are stages 1, 2, and 3 of sleep, and Wake (W) is the duration of time from &quot;lights out,&quot; or bedtime, to the onset of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>Data was not analyzed as number of minutes, as minutes is not a meaningful measurement. It is best measured respective to % TST in outcome measure 2. This was included in the protocol in error and the protocol was not amended.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep</title>
          <description>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) sleep. REM is the period of rapid eye movement sleep, NREM are stages 1, 2, and 3 of sleep, and Wake (W) is the duration of time from &quot;lights out,&quot; or bedtime, to the onset of sleep.</description>
          <population>Data was not analyzed as number of minutes, as minutes is not a meaningful measurement. It is best measured respective to % TST in outcome measure 2. This was included in the protocol in error and the protocol was not amended.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arousal Index</title>
        <description>Arousal Index is the number of arousals and awakenings is registered in the study, and reported as a total number and as a frequency per hour of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Arousal Index</title>
          <description>Arousal Index is the number of arousals and awakenings is registered in the study, and reported as a total number and as a frequency per hour of sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" spread="12"/>
                    <measurement group_id="O2" value="16" spread="7"/>
                    <measurement group_id="O3" value="16" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nocturnal Oxygenation</title>
        <description>Nocturnal oxygenation measured by continuous pulse oximetry during sleep study.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Nocturnal Oxygenation</title>
          <description>Nocturnal oxygenation measured by continuous pulse oximetry during sleep study.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>percent oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" spread="7"/>
                    <measurement group_id="O2" value="86" spread="4"/>
                    <measurement group_id="O3" value="84" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hypopnea Index (HI)</title>
        <description>Hypopnea Index (HI) is the number of hypopneas divided by number of hours of sleep.</description>
        <time_frame>Baseline, and 2 nights (1 night for each intervention)</time_frame>
        <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Continous Positive Airway Pressure Titriation</title>
            <description>Baseline PSG to qualify for randomization.</description>
          </group>
          <group group_id="O2">
            <title>BiPAP Auto SV Advanced</title>
            <description>BiPAP auto SV Advanced
BiPAP auto Advanced: Auto Servo Ventilation Device</description>
          </group>
          <group group_id="O3">
            <title>BiPAP Auto SV 4</title>
            <description>Auto Servo Ventilation Device
BiPAP auto SV4: Auto Servo Ventilation Device</description>
          </group>
        </group_list>
        <measure>
          <title>Hypopnea Index (HI)</title>
          <description>Hypopnea Index (HI) is the number of hypopneas divided by number of hours of sleep.</description>
          <population>8 participants had missing or unscorable data, therefore they are not included in the analysis.</population>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" spread="9"/>
                    <measurement group_id="O2" value="11" spread="15"/>
                    <measurement group_id="O3" value="8" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>All Participants</title>
          <description>All Study participants that were consented to the study.</description>
        </group>
        <group group_id="E2">
          <title>BiPAP Auto SV Advanced</title>
          <description>All participants that received the Philips BiPAP Auto SV Advanced.</description>
        </group>
        <group group_id="E3">
          <title>BiPAP Auto SV 4</title>
          <description>All participants that received the Philips BiPAP Auto SV 4.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Stents</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeremy Powers</name_or_title>
      <organization>Philips</organization>
      <phone>412-542-3669</phone>
      <email>jeremy.powers@philips.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

